Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C7H11NO4S |
| Molecular Weight | 205.232 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)N1CSC[C@H]1C(O)=O
InChI
InChIKey=XBJWOGLKABXFJE-YFKPBYRVSA-N
InChI=1S/C7H11NO4S/c1-2-12-7(11)8-4-13-3-5(8)6(9)10/h5H,2-4H2,1H3,(H,9,10)/t5-/m0/s1
| Molecular Formula | C7H11NO4S |
| Molecular Weight | 205.232 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Telmesteine, a mucoactive agent with strong anti-inflammatory properties. Telmesteine was used in the treatment of respiratory tract disorders. This compound inhibits elastase and collagenase and may be useful in the treatment of skin aging and psoriasis. The anti-inflammatory properties of telmesteine are mediated by blocking PI3K/Akt/IKK activities. Thus, telmesteine can be used as a potent anti-inflammatory agent for skin inflammatory and anti-inflammatory materials in cosmetics,
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:37:54 GMT 2023
by
admin
on
Fri Dec 15 16:37:54 GMT 2023
|
| Record UNII |
124I3FE35T
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C74536
Created by
admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C091508
Created by
admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
|
PRIMARY | |||
|
C74550
Created by
admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
|
PRIMARY | |||
|
124I3FE35T
Created by
admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
|
PRIMARY | |||
|
6573
Created by
admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
|
PRIMARY | |||
|
100000082462
Created by
admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
|
PRIMARY | |||
|
85929
Created by
admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
|
PRIMARY | RxNorm | ||
|
122946-43-4
Created by
admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
|
PRIMARY | |||
|
SUB10873MIG
Created by
admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
|
PRIMARY | |||
|
DTXSID60153804
Created by
admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
|
PRIMARY | |||
|
2582
Created by
admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
|
PRIMARY | |||
|
65946
Created by
admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107621
Created by
admin on Fri Dec 15 16:37:54 GMT 2023 , Edited by admin on Fri Dec 15 16:37:54 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
